India's first nasal Covid vaccine iNCOVACC launched; priced at ₹325/dose
Bharat Biotech’s vaccine dubbed as “game changer”; to offer efficient distribution and easy and pain-free administration.
nasal vaccine
January 2023
December 2022
November 2022
Bharat Biotech's Covid-19 nasal vaccine to cost ₹800 in pvt market, ₹325 for govt supplies
The iNCOVACC vaccine received Indian drug regulator's approval to be used as a booster dose for the adult population.
Covid surge in China: Govt prepared to fulfil medicine, vaccine needs, says Mandaviya
Random RT-PCR sampling of passengers arriving at airports has been started; govt committed to taking appropriate steps, said the health minister.
Bharat Biotech’s intra-nasal vaccine approved as primary, heterologous booster
iNCOVACC becomes the world’s first intranasal vaccine to receive both primary series and heterologous booster approval.
